Agmatine이 GABAA 수용체 길항제로 유도한 촉각이질통에 미치는 효과
Effects of Agmatine on GABAA Receptor Antagonist-induced Tactile Allodynia
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The intrathecal (IT) GABAA receptor antagonist, bicuculline (BIC), results in tactile allodynia (TA) through disinhibition in the spinal cord. Such disinhibition is considered to be an important mechanism for neuropathic pain. Agmatine, an endogenous polyamine, has a neuro-protective effect in the central nervous system. We investigated the analgesic effects and mechanisms of agmatine action on BIC-induced TA. Methods: Male Sprague-Dawley rats, weighting 250−300 g, were subjected to implantations of PE-10 into the lumbar subarachnoid space for IT drug injection. Five days after surgery, either 10μl of normal saline (NS) or agmatine (30μg or 10μg) in 10μl NS were injected 10 min prior to BIC (10μg) or NMDA (5μg). We assessed the degree of TA (graded 0: no response, 1: mild response, 2: moderate response, 3: strong response) every 5 min for 30 min. Areas under curves and degree of TA were expressed as mean ± SEM. Results were analyzed using one-way ANOVA followed by a Tukey test for multiple comparisons. P ＜ 0.05 was considered significant. Results: IT BIC-induced strong TA reached its peak and plateaued between 10 to 15 min. IT NS-NMDA induced mild transient TA for up to 15 min. Preemptive IT AG attenuated IT BIC-induced TA dose dependently and preemptive IT AG10 completely abolished the IT NMDA-induced TA. Conclusions: Preemptive IT AG attenuated the IT BIC-induced TA through inhibitory actions on postsynaptic NMDA receptor activation. AG might be a viable therapeutic option in the treatment of neuropathic pain. (Korean J Pain 2008; 21: 173-178)
Abstract
Background: The intrathecal (IT) GABAA receptor antagonist, bicuculline (BIC), results in tactile allodynia (TA) through disinhibition in the spinal cord. Such disinhibition is considered to be an important mechanism for neuropathic pain. Agmatine, an endogenous polyamine, has a neuro-protective effect in the central nervous system. We investigated the analgesic effects and mechanisms of agmatine action on BIC-induced TA. Methods: Male Sprague-Dawley rats, weighting 250−300 g, were subjected to implantations of PE-10 into the lumbar subarachnoid space for IT drug injection. Five days after surgery, either 10μl of normal saline (NS) or agmatine (30μg or 10μg) in 10μl NS were injected 10 min prior to BIC (10μg) or NMDA (5μg). We assessed the degree of TA (graded 0: no response, 1: mild response, 2: moderate response, 3: strong response) every 5 min for 30 min. Areas under curves and degree of TA were expressed as mean ± SEM. Results were analyzed using one-way ANOVA followed by a Tukey test for multiple comparisons. P ＜ 0.05 was considered significant. Results: IT BIC-induced strong TA reached its peak and plateaued between 10 to 15 min. IT NS-NMDA induced mild transient TA for up to 15 min. Preemptive IT AG attenuated IT BIC-induced TA dose dependently and preemptive IT AG10 completely abolished the IT NMDA-induced TA. Conclusions: Preemptive IT AG attenuated the IT BIC-induced TA through inhibitory actions on postsynaptic NMDA receptor activation. AG might be a viable therapeutic option in the treatment of neuropathic pain. (Korean J Pain 2008; 21: 173-178)
참고문헌 (34)
- Zimmermann M, "Pathobiology of neuropathic pain", Eur J Pharmacol, 429, pp.23~37 (2001)
- Garcia-Larrea L, "Pathophysiology of neuropathic pain: review of experimental models and proposed mechanisms", Presse Med, 37, pp.315~40 (2008)
- Zeilhofer HU, "Loss of glycinergic and GABAergic inhibition in chronic pain-contributions of inflammation and microglia", Int Immunopharmacol, 8, pp.182~7 (2008)
- Yaksh TL, "Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists", Pain, 37, pp.111~23 (1989)
- Sivilotti L, "The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord", J Neurophysiol, 72, pp.169~79 (1994)
- Ishikawa T, "Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist", Neuroscience, 95, pp.781~6 (2000)
- Sosnowski M, "Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism", Anesth Analg, 69, pp.587~92 (1989)
- Yamamoto S, "Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat", Cell Mol Neurobiol, 23, pp.175~85 (2003)
- Olmos G, "Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor", Br J Pharmacol, 127, pp.1317~26 (1999)
- Gadotti VM, "Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice", Brain Res, 1093, pp.116~22 (2006)
- Wang WP, "Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons", Brain Res, 1084, pp.210~6 (2006)
- Szabó C, "Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform", Br J Pharmacol, 118, pp.1659~68 (1996)
- Galea E, "Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine", Biochem J, 316, pp.247~9 (1996)
- Onal A, "Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum", Life Sc, 73, pp.413~28 (2003)
- Roberts JC, "Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse", J Pharmacol Exp Ther, 314, pp.1226~33 (2005)
- Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~6 (1976)
- Whiteside GT, "Cell death in the superficial dorsal horn in a model of neuropathic pain", J Neurosci Res, 64, pp.168~73 (2001)
- Polgár E, "Tactile allodynia can occur in the spared nerve injury model in the rat without selective loss of GABA or GABA(A) receptors from synapses in laminae I-II of the ipsilateral spinal dorsal horn", Neuroscience, 156, pp.193~202 (2008)
- Scholz J, "Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury", J Neurosci, 25, pp.7317~23 (2005)
- Engle MP, "Spinal nerve ligation does not alter the expression or function of GABA(B) receptors in spinal cord and dorsal root ganglia of the rat", Neuroscience, 138, pp.1277~87 (2006)
- Moore KA, "Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord", J Neurosci, 22, pp.6724~31 (2002)
- Schoffnegger D, "Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury", J Physiol, 577, pp.869~78 (2006)
- Coull JA, "Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain", Nature, 424, pp.938~42 (2003)
- Zhang W, "Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats", Neuroscience, 152, pp.502~10 (2008)
- Onaka M, "Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice", Anesthesiology, 84, pp.1215~22 (1996)
- Zhuang ZY, "Role of the CX3CR1", p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine, 2007, pp.21, 642~51
- Halaris A, "Agmatine: metabolic pathway and spectrum of activity in brain", CNS Drugs, 21, pp.885~900 (2007)
- Tan-No K, "Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site", J Pharmacol Sci, 104, pp.39~45 (2007)
- Cízková D, "Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn", Brain Res Bull, 58, pp.161~71 (2002)
- Lee DH, "Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia", Neurosci Lett, 385, pp.179~83 (2005)
- Karadag HC, "Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats", Neurosci Lett, 339, pp.88~90 (2003)
- Abe K, "Agmatine suppresses nitric oxide production in microglia", Brain Res, 872, pp.141~8 (2000)
- Fairbanks CA, "Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury", Proc Natl Acad Sci U S A, 97, pp.10584~9 (2000)
- Hong S, "Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line", BMC Neurosci, 8, pp.81~ (2007)